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Objective: Obsessive-Compulsive disorder (OCD) is one of the greatest and debilitating 
disorders, which many of its patients do not respond to psychotherapy and pharmacotherapy. 
In this regard, paying attention to new treatments such as transcranial direct current stimulation 
(tDCS) is important. The purpose of the present research was to examine the effects of tDCS 
on the obsession-compulsion (OC), anxiety, and depression of a patient suffering from OCD. 
Methods: The present study conducted on a 23-year-old female patient with OCD. tDCS 
sessions were lasted 10 days, one session per day and each session of about 20 minutes with 2.0 
mA intensity. The results of Beck depression inventory, Hamilton anxiety rating scale, and Yale 
Brown obsessive-compulsive scale  showed decrease in OC, depression, and anxiety symptoms 
after 10 sessions of tDCS.
Results: The results of the present research using cathodal tDCS on orbitofrontal cortex in 
10 sessions showed that this montage is a powerful and successful treatment for patients with 
OCD and alleviate their OC, depression, and anxiety symptoms.
Conclusion: The data were analyzed by diagram analysis and improvement percentage. This 
study showed that anodal tDCS on O2 and cathodal tDCS on orbitofrontal cortex improved 
OC, anxiety and depression symptoms. However, our findings give introductory confirmation 
that our patient with OCD has a positive response to cathode tDCS of the OFC. 
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bsessive-compulsive disorder (OCD) is a 
debilitating psychiatric disorder with 2% 
lifetime prevalence (Ruscio, Sten, ldvin, 
Chiu, & Kessler, 2010). It is one of the most prevalent psy-
chological disorders. OCD leads to terrible impairments in 
relationship with other people and occupational responsibil-
ity (Fontenelle, Fontenelle, & Borges, 2010). It is supposed 
that OCD will become the sixth most debilitating psychi-O
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atric disorder in 2015 (Mathers, et al., 2003). Only 40% to 
60% of these patients respond to available treatments such 
as pharmacotherapy (Foa, Liebowitz, & Kozak, 2005), also 
cognitive-behavior therapy was effective only for some of 
these patients (Foa, Liebowitz, & Kozak, 2005).
In many research studies, OCD is comorbid with de-
pression and anxiety (Ivarsson, Melin, & Wallin, 2008; 
Peris et al., 2010). Depression leads to drawback of treat-
ment outcomes for individuals with OCD (Storch et al., 
2008). Anxiety also is more prevalent than depression in 
OCD (Ivarsson, Melin, & Wallin, 2008; Langley, Lewin, 
Bergman, Lee, & Piacentini, 2010). The severity of anxiety 
will be great if the symptoms of OCD increase (Langley 
et al., 2010). Regarding the high prevalence of OCD and 
its demolishing effects on patients’ life, it seems neces-
sary to consider new technologies to treat OCD patients.
According to conducted research studies over past 20 
years, there is an increased activity in the orbitofrontal cor-
tex (OFC) in patients with OCD (Del Casale et al., 2011; 
Milad & Rauch, 2012), including the dorsolateral prefron-
tal cortex (DLPFC), orbitofrontal cortex (OFC), medial 
prefrontal cortex, anterior cingulated gyrus, supplementary 
motor area (SMA), and basal ganglia (Shah, Pesiridou, & 
Baltuch, 2008). The connections of the ventral striatum with 
prefrontal cortices are considered  to be increased in these 
patients (Del Casale et al., 2011; Shah, Pesiridou, & Bal-
tuch, 2008). OFC plays a major role in the pathophysiology 
of OCD because obsessions and compulsions are mediated 
by hyper activity of the orbito-frontal cortex either bilater-
ally (Alptekin et al., 2001) or unilaterally (left side) (Baxter, 
Schwartz, & Mazziotta, 1998; Swedo et al., 1992).
Further pathophysiological insight came from the appli-
cation of the noninvasive brain stimulation techniques, i.e. 
transcranial magnetic stimulation (TMS) and transcranial 
direct current stimulation (tDCS). Noninvasive brain stimu-
lation techniques such as tDCS is a vigorous and convenient 
technique to moderate brain activity. Anodal tDCS increases 
excitability of cortex in the special area of the brain, while 
cathodal tDCS decreases excitability of cortex in the speci-
fied area of the brain (Nitsche & Paulus, 2000) by producing 
low-intensity electric field (<1 V/m) (Datta et al., 2009).
In other words, cathodal and anodal stimulations hyper-
polarize and depolarize neurons respectively (Priori, Hallet, 
& Rothwell, 2009; Nitsche et al., 2003). This technique has 
shown optimistic results in many neuropsychiatric illnesses 
(Kuo, Paulus, & Nitsche, 2014) and also has some advan-
tages such as low cost, ease of use, portability, and safety 
(Volpato et al., 2013; Brunoni et al., 2011) over other tech-
niques such as repetitive transcranial magnetic stimulation.
Previous studies have reported that noninvasive techniques 
such as tDCS alleviates the symptoms of treatment-resistant 
OCD (Jaafari et al., 2012). Volpato et al. (2013) found out 
that cerebellar-tDCS on DLPFC decreased anxiety and de-
pressive symptoms but not OC symptoms in patients with 
treatment-resistant OCD. OC symptoms decreased when 
stimulation was delivered over the SMA or the OFC (Ber-
lim, Neufeld, & Van den Eynde, 2013). In a study by Mon-
dino, Haesebaert, Poulet, Saoud and Brunelin (2015) which 
used cathodal tDCS on the left OFC (above FP1) and an-
odal tDCS on the contralateral orbitofrontal region (above 
O2), they observed considerable decrease (26%) in symp-
toms of patients with treatment-resistant OCD.
According to the mentioned studies, cathodal tDCS over 
the pre-SMA, (rather than anodal tDCS) significantly alle-
viates OCD symptoms (Senco et al., 2015), but it has not yet 
been identified whether tDCS can reduce simultaneously 
depression, anxiety, OC symptoms or not. In the present 
study, we used tDCS because it has an impact on corticostri-
atal and corticothalamic loops involved in the pathology of 
OCD (Polania, Paulus, & Nitsche, 2012). Besides, we used 
Beck depression inventory (BDI) and Hamilton anxiety rat-
ing scale (HARS) tests to evaluate the impact of tDCS on 
depression, anxiety, and OC symptoms.
Considering that a few studies have directly dealt with this 
issue (no research in Iran and a few in abroad), as well as 
the novelty of tDCS, the present study is the first to investi-
gate the effect of tDCS efficacy on the treatment for OCD, 
and especially to evaluate the effect of tDCS on depression, 
anxiety, and OC symptoms.
2. Methods
In this study, single-subject experimental trial was used in 
which, firstly, in stage A, primary condition of a patient was 
assessed by Yale Brown obsessive compulsive scale (Y-
BOCS), Beck depression inventory (BDI), and Hamilton 
anxiety rating scale (HARS). Then, in stage B, experimen-
tal trial was done and the subject’s condition in these scales 
was again assessed in follow up stage. Our participant was 
a 23-year-old female student, diagnosed with obsessive-
compulsive disorder (based on DSM-V criteria) which 
was referred by a psychiatrist to receive noninvasive brain 
stimulation treatment because of the failure in response to 
other treatments. She had a one year history of this disease 
characterized by obsessions (religious type) without com-
pulsion. Previous treatment with sertraline (for 3 months) 
did not improve her symptoms. Obsession symptoms of 
patients began one year ago when university exams started. 
Obsession symptoms were not found in her family in Mini-
mental state examination. She had normal communication 
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with her family and friends and did not report any problem 
in these areas. Patient was informed about the purpose of 
the study,  and gave her written informed consent. 
The cathode electrode was placed on the left orbito frontal 
cortex (OFC) and anode electrode on the contra lateral re-
gion (O2). We used a direct current of 2.0 mA for 20 minutes 
per day for 10 sessions. The 25-cm2 rubber electrodes with 
cotton material, which was moistened with saline to reduce 
impedance were used. For assessment of obsession/com-
pulsion, anxiety, and depression symptoms, we used the Y-
BOCS, HARS, and BDI at the first, fifth, and last session of 
the treatment and 2 weeks later as follow up. It is important 
to note that tDCS was started after providing consent form 
and this research took place at a clinical psychology clinic 
(a noninvasive center). Obsession, depression, and anxiety 
symptoms improved during the 10 session’s of treatment.
The inclusion criteria included 1) Diagnosis of OCD 
by psychiatrist according to the DSMV and psychologi-
cal interview, 2) Y-BOCS scores of 17 points or higher 
(Goodman et al., 1989), 3) Under no other therapy such as 
psychotherapy or pharmacotherapy, 4) Without comorbid 
psychiatric disorders, and 5) No drug abuse. The exclusion 
criteria included 1) Having metal implants, 2) Not meeting 
DSMV criteria for OCD, 3) Using drugs such as clomip-
ramine, bupropion.
 Yale-Brown obsessive compulsive scale (Y-BOCS): This 
scale was developed by Goodman et al., (1989) to measure 
OCD. It consists of 10 observer-rated items scored on a 
5-point Likert-type scale. It is widely used in clinical trials 
and its administration only takes about 10 to 15 minutes. The 
scale has a good reliability and validity. Range of severity 
includes: 0–7=Subclinical, 8–15=Mild, 16–23=Moderate, 
24–31=Severe, and 32–40=Extreme. In a study conducted 
by Rajezi Esfahani, Motaghipour, Kamkari, Zahiredin and 
Janbozorgi (2012), levels of internal consistency scores for 
symptom checklist was 0.97 and for severity scale 0.95. 
Also, split-half reliability for symptom checklist was 0.93 
and for severity scale 0.89. Its test-retest reliability was 0.99.
Hamilton anxiety rating scale (HARS):This scale was 
developed by Hamilton (1959). It is widely used as an as-
sessment instrument for anxiety symptoms in psychiatry, 
and is designed to evaluate changes in symptoms over time. 
It consists of 14 items that cover 13 symptoms of anxiety. 
Each item is rated on a 4-point scale (0=not present to 4=se-
vere) on an unanchored severity scale. The score range is 
0–56. Those who score 5 or less are considered as having 
no anxiety. Other categories are as follows: 6–14=mild 
anxiety; 15–28=moderate anxiety; 29–42=severe anxiety, 
and 43–56=very severe anxiety. In Iran, HARS has been 
validated by Kavyani, Mossavi and Mohit (2001) and was 
reported to have high reliability and validity.
Beck Depression Inventory (BDI): This scale is a 21-item, 
self-rating scale, which assesses depression. It consist of dif-
ferent symptoms of depression such as (i.e. agitation, worth-
lessness, concentration difficulty, loss of energy, weight loss, 
body image change, work difficulty, and somatic preoccu-
pation), which rated from 0 to 3 with 4 possible answers. 
The Chronbach’s alpha for BDI was=0.86 and for BDI-II 
was=0.92 which represent high reliabilty (Psychological 
Corporation Website, 2003). The standard cut-off scores 
are as follows: 0–9=minimal, 10–18=mild, 19–29=moder-
ate, 30–63= severe. Higher total scores indicate more severe 
depressive symptoms. Internal consistency of this scale in 
Iranian students was 0.87, and its test-retest reliability in a 
week was 0.73 (Dobson & Mohammad Khani, 2007).
3. Results
For analyzing the data and calculating changes, diagram 
analysis and improvement percentage were used. Table 1 
shows the descriptive statistics of YBOCS, BDI, and HARS 
scores from first to last and follow up sessions. At the first 
session of the treatment, the patient scored 28 in YBOCS, 
32 in HARS and 48 in BDI.
As seen in Table 1, in baseline, the scores of the patient 
regarding Y-BOCS was 28, in BDI was 48, and in HARS 
was 32. After 10 sessions of treatment, the scores of these 
scales reduced significantly, and after 2 weeks of treatment, 
the patient reported significantly suitable respones to this 
treatment (Figure 1). Also, there were no significant clini-
cal or cognitive side effects. Improvement percentage for 
Y-BOCS was 64, for BDI was 87, and for HARS was 100. 
Mehri Mowlaie. M., & et al. (2016). Transcranial direct current stimulation on obsession-compulsion, anxiety .Journal of Practice in Clinical Psychology; 4(2), 75-80.
Table 1. Descriptive statistics of the Y-BOCS, BDI, and HARS scores.
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These percentages indicated that tDCS has significant ther-
apeutic effects on OC, depression, and anxiety.
4. Discussion
Noninvasive brain stimulation techniques have found pro-
gressive applications in the OCD field, providing an impor-
tant contribution to our understanding of OCD pathophysi-
ology, and offering new opportunities for treatment. The 
present study aimed to assess the decrease in obsession, de-
pression, and anxiety symptoms via tDCS in a patient with 
OCD. Evidently, hyperactivation of prefrontal-thalamic 
circuits and the lack of inhibition of the cortico-striato-thal-
amo-cortical pathways are implicated in OCD pathophysi-
ology (Alexander, Crutcher, & DeLong, 1989).
According to this theory, DLPFC, OFC, ACC and stria-
tum (specifically the caudate) will be the most important 
structures (Aronson, Katnani, & Eskandar, 2014) involv-
ing in depression, anxiety, and obsession-compulsion. In 
line with previous studies, we found  that cortical cathodal 
stimulation on OFC will decrease obsession (Jaffari et al., 
2012; Berlim, Neufeld, & Van den Eynde, 2013; Mondino et 
al., 2015) depression, and anxiety (Volpato et al., 2013). The 
present research is inconsistent with Volpato et al. (2013)
which stated that tDCS only decrease anxiety and depres-
sive symptoms but not OC symptoms. Our results showed 
that tDCS can have significant equal impact on depression, 
anxiety, and OC symptoms.
It is important to note that Mondino et al. (2015) in their 
research found after 10 sessions of tDCS, the symptoms of 
OC did not subside immediately after 10 sessions of tDCS 
but our patient showed considerable decrease in depression, 
anxiety, and OC symptoms after 10 sessions of tDCS. In 
fact, the symptoms of OC reduced 64.28%, symptoms of 
anxiety 87.5%, and depression 87.5% after 10 sessions. In 
order to confirm our results, the patient was asked to com-
plete Y-BOCS, HARS, and BDI after 2 weeks, and the re-
sults showed decrease in these symptoms after this interval.
Our other results showed that tDCS decreases anxiety 
symptoms in OCD patient. This finding is consistent with 
some other studies (Del Casale et al., 2011; Polonia, Paulus, 
& Nitsche, 2012; Sakai et al., 2011). Dysfunction in caudate 
nucleus leads to hyperactivity in orbitofrontal and anterior 
cingulate cortices which are respomsible areas of obsessive 
thought and anxiety. According to Del Casale et al., (2011) 
and Sakai et al. (2011), the contact of the ventral striatum 
with prefrontal cortices are considered to increased in these 
patients.
Plonia et al. (2012) showed that tDCS has an impact on 
functional cortico subcortical networks, including cortico-
striatal, and cortico-thalamic loops, which are involved in 
these disorders. The other results of our research showed 
that tDCS has incredible effect on depression. This finding 
is consistent with the findings of other studies (Fregni et al., 
2006; Boggio et al., 2008; Loo et al., 2012; Bennabi et al., 
2015). According to Berlim, Neufeld and Van den Eynde 
(2013), the rationale for considering tDCS as an effective 
Figure 1. Y-BOCS, BDI, and HARS scores at baseline, the fifth day, last day, and 14th days 
follow up.
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treatment in depression is inducing functional changes in 
resting membrane potential and cerebral blood flow.
Like other studies, our research has some limitations too. 
First of all, it is a case study; therefore our results may not 
be generalized to other patients with OCD. To resolve this 
limitation, further controlled studies in large patient groups 
are needed. However, these results suggest that tDCS inhib-
it the orbitofrontal cortex while activate the occipital area 
above O2 has an interesting therapeutic potential in obses-
sion-compulsion disorder. Therefore, in a practical way, this 
montage can be used by therapists to simultaneously treat 
obsession, anxiety, and depression symptoms.
In conclusion, the results of the present research showed 
that tDCS by using anode electrode on O2 and cathode 
electrode on OFC would safely, conveniently, and inexpen-
sively decrease OC, anxiety, and depression symptoms in 
patients with OCD. Also as few studies has been done to 
investigate the impact of brain stimulation on these patients, 
this study might be the practical one and guide behavior 
therapists to combine their therapies with noninvasive brain 
stimulation  in order to increase beneficial effects of tDCS.
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